Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1058 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-02-06 (marketbeat.com)
E. Ohman J or Asset Management AB Has $480,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
E. Ohman J or Asset Management AB grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 225.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,600 shares of th
Read more
2024-11-25 (marketbeat.com)
Horizon Kinetics Asset Management LLC Sells 45,619 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Horizon Kinetics Asset Management LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 28.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1
Read more
2024-11-02 (defenseworld.net)
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Creative Planning
Read Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Creative Planning at Defense World
Read more
2024-09-29 (marketbeat.com)
APG Asset Management N.V. Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
APG Asset Management N.V. increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 61,017 shares of the medical research compa
Read more
2024-09-24 (defenseworld.net)
1832 Asset Management L.P. Acquires New Position in Charles River Laboratories International, Inc. (NYSE:CRL)
1832 Asset Management L.P. bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Read more
2024-06-07 (appliedclinicaltrialsonline.com)
In Focus: Amid Heightened Industry Rules on Sustainability, How are CROs Faring?
With investors embracing the new regulations, a look at the progress CROs are making in their sustainability efforts
Read more
2024-03-18 (defenseworld.net)
Exchange Traded Concepts LLC Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Exchange Traded Concepts LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Read more
2024-02-16 (yahoo.com)
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
Comprehensive SWOT analysis based on Charles River Laboratories International Inc's latest SEC 10-K filing.
Read more
2023-12-29 (defenseworld.net)
State of Alaska Department of Revenue Reduces Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
State of Alaska Department of Revenue decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).
Read more